Method for determining the prognosis of a patient with a neurological disease
CA 2275404 C · Owner: Nova Molecular, Inc. · Inventors: Sevigny, Pierre; Schappert, Keith; Wiebusch, Heiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trails of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 1997 and granted February 8, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 16, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.